{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Yojana Gadiya",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "he novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/3c93a65dc48e6786fe29ae55aa36cf9a902fe8c6/export/conso-names.belns",
      "DOID": "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
    },
    "path": "hdac6/fan2018.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Our previous study demonstrated that MPT0G211 (Fig. 1a) exhibited potent HDAC6 inhibition (IC50 value = 0.291 nM) and was 1000-fold more selective for HDAC6 compared with the other HDAC isoforms [11].",
      "key": "0f939f4bef04a87bf770abc746395183",
      "line": 82,
      "relation": "decreases",
      "source": 2,
      "target": 24
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, MPT0G211 concentration-dependently increased the acetylation of α-tubulin in SH-SY5Y and Neuro-2a cells, the common used neuronal cell lines in the study of AD, at concentrations ranging from 0.1 to 1 μM without affecting the acetylation of histones, which is consistent with the selective inhibition of HDAC6 (Fig. 1b, c).",
      "key": "20e6e266dc156efcb71b3c21a88aaaaf",
      "line": 96,
      "relation": "increases",
      "source": 2,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Immunohistochemical analysis revealed that mutant transgenes mediated increases in total tau and tau phosphorylation at Ser396/Ser404 in the hippocampal CA1 region of mice that harbor tauP301L mutant transgene; MPT0G211 treatment significantly downregulated p-Tau (S396) and p-Tau (S404) expression and increased acetyl-α-tubulin accumulation in the 3×Tg-AD mice brain (Fig. 6b).These results provide strong support that MPT0G211 treatments can ameliorate Alzheimer’s deficits.",
      "key": "8372778575d0473e6aa394d781a61e2d",
      "line": 308,
      "relation": "increases",
      "source": 2,
      "target": 36
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, MPT0G211 concentration-dependently increased the acetylation of α-tubulin in SH-SY5Y and Neuro-2a cells, the common used neuronal cell lines in the study of AD, at concentrations ranging from 0.1 to 1 μM without affecting the acetylation of histones, which is consistent with the selective inhibition of HDAC6 (Fig. 1b, c).",
      "key": "e5a1aaa9294ef1f65194639f7ec54e76",
      "line": 97,
      "relation": "causesNoChange",
      "source": 2,
      "target": 39
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, MPT0G211 treatment did not result in any significant cytotoxicity in SH-SY5Y and Neuro-2a cells after 24 h (Fig. 1d), suggesting that the concentrations used in this study (0.01–1 μM) did not cause cell death.",
      "key": "1e93c0f97d4dc5918e4047a88f762a7a",
      "line": 109,
      "relation": "decreases",
      "source": 2,
      "target": 43
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, MPT0G211 treatment did not result in any significant cytotoxicity in SH-SY5Y and Neuro-2a cells after 24 h (Fig. 1d), suggesting that the concentrations used in this study (0.01–1 μM) did not cause cell death.",
      "key": "4b748108a32b9f1f079db94f2ab3098f",
      "line": 110,
      "relation": "decreases",
      "source": 2,
      "target": 5
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As reported, MPT0G211 treatment significantly inhibited the phosphorylation of tau Ser396 in both cell lines (Fig. 2e, f).",
      "key": "3b211a5b43ddc22e30183b7e3b92426e",
      "line": 142,
      "relation": "decreases",
      "source": 2,
      "target": 29
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "MPT0G211 treatment significantly attenuated the phosphorylation of tau Ser396 and Ser404 in both cell lines (Fig. 5a); no marked changes in CDK5, p25, or p35 expression were associated with MPT0G211-induced phospho-tau downregulation; however, significant phospho-GSK3β increases on Ser9 through Akt phosphorylation were associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment (Fig. 5b).In addition, a decrease in phospho-GSK3β on Ser216 was also observed.",
      "key": "69682eb388ae8546870fea2ffbc3d319",
      "line": 258,
      "relation": "decreases",
      "source": 2,
      "target": 29
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As reported, Aβ 1–40-induced significant p-GSK3β (Ser9) attenuation and increase in p-tau (Ser396); MPT0G211 treatment diminished GSK3β activity and Aβ 1–40-induced tau phosphorylation (Fig. 5c).",
      "key": "364d3ab2c25469aad6447b7eb6ead481",
      "line": 277,
      "relation": "decreases",
      "source": 2,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Immunohistochemical analysis revealed that mutant transgenes mediated increases in total tau and tau phosphorylation at Ser396/Ser404 in the hippocampal CA1 region of mice that harbor tauP301L mutant transgene; MPT0G211 treatment significantly downregulated p-Tau (S396) and p-Tau (S404) expression and increased acetyl-α-tubulin accumulation in the 3×Tg-AD mice brain (Fig. 6b).These results provide strong support that MPT0G211 treatments can ameliorate Alzheimer’s deficits.",
      "key": "076c48f4e6e7b539a9d9e1da53ac194d",
      "line": 306,
      "relation": "decreases",
      "source": 2,
      "target": 29
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, cytosolic levels of tau associated with membranes and, in aggregates, were significantly increased in SH-SY5Y cells cotransfected with hAPP 695 and hTau P301L (Fig. 3a). Treatment of the transfectants with MPT0G211 significantly reduced the levels of aggregated tau (Fig. 3a).",
      "key": "38d48ab47870ab1ee2b7bdde9a8fd0d0",
      "line": 173,
      "object": {
        "location": {
          "name": "Tau aggregates",
          "namespace": "CONSO"
        }
      },
      "relation": "decreases",
      "source": 2,
      "target": 25
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In cells treated with MPT0G211, coimmunoprecipitation of ubiquitin with p-tau (Ser396) clearly increased (Fig. 4b), and the level of polyubiquitinated proteins significantly accumulated (Fig. 4c).",
      "key": "145db6d2ab2dac821f2b92edab032dd0",
      "line": 210,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 2,
      "target": 25
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, MPT0G211 treatment clearly enhanced the acetylation of Hsp90, which caused the downregulation of HDAC6/Hsp90 binding (Fig. 4a).",
      "key": "9c025d77dd177fb78d1bed04b3ef1ce9",
      "line": 199,
      "relation": "increases",
      "source": 2,
      "target": 34
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In cells treated with MPT0G211, coimmunoprecipitation of ubiquitin with p-tau (Ser396) clearly increased (Fig. 4b), and the level of polyubiquitinated proteins significantly accumulated (Fig. 4c).",
      "key": "880bdb22ffe2328ad71702e18229af8c",
      "line": 208,
      "relation": "increases",
      "source": 2,
      "target": 30
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "MPT0G211 treatment significantly attenuated the phosphorylation of tau Ser396 and Ser404 in both cell lines (Fig. 5a); no marked changes in CDK5, p25, or p35 expression were associated with MPT0G211-induced phospho-tau downregulation; however, significant phospho-GSK3β increases on Ser9 through Akt phosphorylation were associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment (Fig. 5b).In addition, a decrease in phospho-GSK3β on Ser216 was also observed.",
      "key": "53cd0bcf616ddf238194bfff2eba7f6c",
      "line": 259,
      "relation": "decreases",
      "source": 2,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Immunohistochemical analysis revealed that mutant transgenes mediated increases in total tau and tau phosphorylation at Ser396/Ser404 in the hippocampal CA1 region of mice that harbor tauP301L mutant transgene; MPT0G211 treatment significantly downregulated p-Tau (S396) and p-Tau (S404) expression and increased acetyl-α-tubulin accumulation in the 3×Tg-AD mice brain (Fig. 6b).These results provide strong support that MPT0G211 treatments can ameliorate Alzheimer’s deficits.",
      "key": "35b6c27162b2f10c3d24b0be6a263a68",
      "line": 307,
      "relation": "decreases",
      "source": 2,
      "target": 31
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "MPT0G211 treatment significantly attenuated the phosphorylation of tau Ser396 and Ser404 in both cell lines (Fig. 5a); no marked changes in CDK5, p25, or p35 expression were associated with MPT0G211-induced phospho-tau downregulation; however, significant phospho-GSK3β increases on Ser9 through Akt phosphorylation were associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment (Fig. 5b).In addition, a decrease in phospho-GSK3β on Ser216 was also observed.",
      "key": "df93936428cd748061e879d180bd6ce1",
      "line": 260,
      "relation": "causesNoChange",
      "source": 2,
      "target": 18
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "MPT0G211 treatment significantly attenuated the phosphorylation of tau Ser396 and Ser404 in both cell lines (Fig. 5a); no marked changes in CDK5, p25, or p35 expression were associated with MPT0G211-induced phospho-tau downregulation; however, significant phospho-GSK3β increases on Ser9 through Akt phosphorylation were associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment (Fig. 5b).In addition, a decrease in phospho-GSK3β on Ser216 was also observed.",
      "key": "ee336a9b4b391746088d22a5bba69b13",
      "line": 261,
      "relation": "causesNoChange",
      "source": 2,
      "target": 19
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "MPT0G211 treatment significantly attenuated the phosphorylation of tau Ser396 and Ser404 in both cell lines (Fig. 5a); no marked changes in CDK5, p25, or p35 expression were associated with MPT0G211-induced phospho-tau downregulation; however, significant phospho-GSK3β increases on Ser9 through Akt phosphorylation were associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment (Fig. 5b).In addition, a decrease in phospho-GSK3β on Ser216 was also observed.",
      "key": "a22aaa9a7e338ba704344e2814badad2",
      "line": 262,
      "relation": "increases",
      "source": 2,
      "target": 17
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "MPT0G211 treatment significantly attenuated the phosphorylation of tau Ser396 and Ser404 in both cell lines (Fig. 5a); no marked changes in CDK5, p25, or p35 expression were associated with MPT0G211-induced phospho-tau downregulation; however, significant phospho-GSK3β increases on Ser9 through Akt phosphorylation were associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment (Fig. 5b).In addition, a decrease in phospho-GSK3β on Ser216 was also observed.",
      "key": "2a290978c8455271393dfe33cb99a4b7",
      "line": 265,
      "relation": "decreases",
      "source": 2,
      "target": 21
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As reported, Aβ 1–40-induced significant p-GSK3β (Ser9) attenuation and increase in p-tau (Ser396); MPT0G211 treatment diminished GSK3β activity and Aβ 1–40-induced tau phosphorylation (Fig. 5c).",
      "key": "8e0e94dfcbd03dc7fd97625823b18c54",
      "line": 276,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Oral administration of MPT0G211 significantly ameliorated memory impairment (Fig. 6a).",
      "key": "135adf9bf9d576acda0ff719b20218db",
      "line": 288,
      "relation": "increases",
      "source": 2,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "These results clearly indicated that MPT0G211 can penetrate the BBB, where it potentially ameliorates learning and memory deficits.",
      "key": "775abeacdd384a739da9de35c5584b3e",
      "line": 319,
      "relation": "increases",
      "source": 2,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Immunohistochemical analysis revealed that mutant transgenes mediated increases in total tau and tau phosphorylation at Ser396/Ser404 in the hippocampal CA1 region of mice that harbor tauP301L mutant transgene; MPT0G211 treatment significantly downregulated p-Tau (S396) and p-Tau (S404) expression and increased acetyl-α-tubulin accumulation in the 3×Tg-AD mice brain (Fig. 6b).These results provide strong support that MPT0G211 treatments can ameliorate Alzheimer’s deficits.",
      "key": "6944e7764f30e7ee9ed31965fef29fd4",
      "line": 309,
      "relation": "decreases",
      "source": 2,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "These results clearly indicated that MPT0G211 can penetrate the BBB, where it potentially ameliorates learning and memory deficits.",
      "key": "2c6f72b9f94bf6b2d9ce802738ee37c7",
      "line": 317,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Blood",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Brain",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 2,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "These results clearly indicated that MPT0G211 can penetrate the BBB, where it potentially ameliorates learning and memory deficits.",
      "key": "501b68d562769e20dbe3da7572ec90c0",
      "line": 318,
      "relation": "increases",
      "source": 2,
      "target": 8
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Since Hsp90 is a substrate of HDAC6, the downregulation of the expression or activity of HDAC6 has been reported to promote Hsp90 acetylation, thereby favoring tau degradation [17,18].",
      "key": "c4c091fca97f46658381b0267803bb2f",
      "line": 181,
      "relation": "association",
      "source": 24,
      "target": 33
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Since Hsp90 is a substrate of HDAC6, the downregulation of the expression or activity of HDAC6 has been reported to promote Hsp90 acetylation, thereby favoring tau degradation [17,18].",
      "key": "5774a27be8c2fe0843bad83df85ae182",
      "line": 182,
      "relation": "decreases",
      "source": 24,
      "target": 34
    },
    {
      "key": "6541dd28eb94e64293e0bf2b24355a59",
      "relation": "partOf",
      "source": 24,
      "target": 10
    },
    {
      "key": "5e62edb6575e6807b74e052fb9ef4439",
      "relation": "hasVariant",
      "source": 35,
      "target": 36
    },
    {
      "key": "fb3fcd64487fc294074cd1dc8d7558d6",
      "relation": "hasVariant",
      "source": 38,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, Aβ can increase the accumulation of tau aggregates as well as NFTs, leading to synaptic dysfunction and eventually neuronal death [2,7].",
      "key": "5346a95218e206930008cf009fa499ab",
      "line": 119,
      "relation": "increases",
      "source": 1,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, Aβ can increase the accumulation of tau aggregates as well as NFTs, leading to synaptic dysfunction and eventually neuronal death [2,7].",
      "key": "61114e5e373989ac7c78e8d562f5adc4",
      "line": 120,
      "relation": "increases",
      "source": 1,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, Aβ can increase the accumulation of tau aggregates as well as NFTs, leading to synaptic dysfunction and eventually neuronal death [2,7].",
      "key": "51f2c50b9231c77a9041fd56b123e876",
      "line": 121,
      "relation": "increases",
      "source": 11,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, Aβ can increase the accumulation of tau aggregates as well as NFTs, leading to synaptic dysfunction and eventually neuronal death [2,7].",
      "key": "547fb9da0a02fe202fa86a3b9cb58a92",
      "line": 122,
      "relation": "increases",
      "source": 37,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, Aβ can increase the accumulation of tau aggregates as well as NFTs, leading to synaptic dysfunction and eventually neuronal death [2,7].",
      "key": "637689f2f20181feb8f73020c3324a91",
      "line": 123,
      "relation": "increases",
      "source": 42,
      "target": 7
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "The phosphorylation of tau Ser396 was significantly increased in the cells transfected with P301L, and tau was hyperphosphorylated in cells cotransfected with hAPP 695 in SH-SY5Y and Neuro-2a cells (Fig. 2c, d).",
      "key": "6188376298f45d20ed2aec11021d0b11",
      "line": 134,
      "relation": "increases",
      "source": 32,
      "target": 29
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",
      "key": "b78dc6d4637c0e5fff2e4c52d0856081",
      "line": 237,
      "relation": "increases",
      "source": 32,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Immunohistochemical analysis revealed that mutant transgenes mediated increases in total tau and tau phosphorylation at Ser396/Ser404 in the hippocampal CA1 region of mice that harbor tauP301L mutant transgene; MPT0G211 treatment significantly downregulated p-Tau (S396) and p-Tau (S404) expression and increased acetyl-α-tubulin accumulation in the 3×Tg-AD mice brain (Fig. 6b).These results provide strong support that MPT0G211 treatments can ameliorate Alzheimer’s deficits.",
      "key": "f2442cb608e177121b4a7c79b480e94b",
      "line": 304,
      "relation": "increases",
      "source": 32,
      "target": 29
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, cytosolic levels of tau associated with membranes and, in aggregates, were significantly increased in SH-SY5Y cells cotransfected with hAPP 695 and hTau P301L (Fig. 3a). Treatment of the transfectants with MPT0G211 significantly reduced the levels of aggregated tau (Fig. 3a).",
      "key": "ef41412a88b3a4cb26e66d738b705dfb",
      "line": 169,
      "object": {
        "location": {
          "name": "cytosol",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 32,
      "target": 25
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, cytosolic levels of tau associated with membranes and, in aggregates, were significantly increased in SH-SY5Y cells cotransfected with hAPP 695 and hTau P301L (Fig. 3a). Treatment of the transfectants with MPT0G211 significantly reduced the levels of aggregated tau (Fig. 3a).",
      "key": "76a869c4fc0b09b57f885d93580acde6",
      "line": 171,
      "object": {
        "location": {
          "name": "Tau aggregates",
          "namespace": "CONSO"
        }
      },
      "relation": "increases",
      "source": 32,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Immunohistochemical analysis revealed that mutant transgenes mediated increases in total tau and tau phosphorylation at Ser396/Ser404 in the hippocampal CA1 region of mice that harbor tauP301L mutant transgene; MPT0G211 treatment significantly downregulated p-Tau (S396) and p-Tau (S404) expression and increased acetyl-α-tubulin accumulation in the 3×Tg-AD mice brain (Fig. 6b).These results provide strong support that MPT0G211 treatments can ameliorate Alzheimer’s deficits.",
      "key": "4015c821a5c11f9afced6be19ee20d87",
      "line": 303,
      "relation": "increases",
      "source": 32,
      "target": 25
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As indicated, plasmid cotransfection significantly increased HDAC6/Hsp90 binding (Fig. 4a).",
      "key": "d42001a2c9bc1e933691076945f6250c",
      "line": 191,
      "relation": "increases",
      "source": 32,
      "target": 10
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",
      "key": "910fd0849204c02c7fc7a3984122936c",
      "line": 239,
      "relation": "increases",
      "source": 32,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Immunohistochemical analysis revealed that mutant transgenes mediated increases in total tau and tau phosphorylation at Ser396/Ser404 in the hippocampal CA1 region of mice that harbor tauP301L mutant transgene; MPT0G211 treatment significantly downregulated p-Tau (S396) and p-Tau (S404) expression and increased acetyl-α-tubulin accumulation in the 3×Tg-AD mice brain (Fig. 6b).These results provide strong support that MPT0G211 treatments can ameliorate Alzheimer’s deficits.",
      "key": "e2bf4c80ddf73cc3a76484d935fd3646",
      "line": 305,
      "relation": "increases",
      "source": 32,
      "target": 31
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",
      "key": "bd4c11c45f25b63e112cb63cc99c4aa1",
      "line": 241,
      "relation": "causesNoChange",
      "source": 32,
      "target": 27
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",
      "key": "d7aed4325609225ce6126e1626f5beed",
      "line": 243,
      "relation": "causesNoChange",
      "source": 32,
      "target": 28
    },
    {
      "key": "1cb345f817331216b34da4f99d0b9234",
      "relation": "hasVariant",
      "source": 25,
      "target": 32
    },
    {
      "key": "deebc6415a1d74c0501fe5fae6165d64",
      "relation": "hasVariant",
      "source": 25,
      "target": 29
    },
    {
      "key": "b5ef526ab5a17da51fd96bb875e02aac",
      "relation": "hasVariant",
      "source": 25,
      "target": 26
    },
    {
      "key": "df14cc8bb645a4096e283452214656c0",
      "relation": "hasVariant",
      "source": 25,
      "target": 30
    },
    {
      "key": "e9808fec4b7de2906ee3a9ab9d1ef29e",
      "relation": "hasVariant",
      "source": 25,
      "target": 31
    },
    {
      "key": "66a0ff7d5f221b0d68cbc5dbafef81f5",
      "relation": "hasVariant",
      "source": 25,
      "target": 27
    },
    {
      "key": "55a0cc9e48187fc8d6cfd504159557bb",
      "relation": "hasVariant",
      "source": 25,
      "target": 28
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "The phosphorylation of tau Ser396 was significantly increased in the cells transfected with P301L, and tau was hyperphosphorylated in cells cotransfected with hAPP 695 in SH-SY5Y and Neuro-2a cells (Fig. 2c, d).",
      "key": "9ca800d6998ed247c1302fcc1a79716b",
      "line": 135,
      "relation": "increases",
      "source": 15,
      "target": 26
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, cytosolic levels of tau associated with membranes and, in aggregates, were significantly increased in SH-SY5Y cells cotransfected with hAPP 695 and hTau P301L (Fig. 3a). Treatment of the transfectants with MPT0G211 significantly reduced the levels of aggregated tau (Fig. 3a).",
      "key": "1830b2409cbfc4dde5c3b71aba306eaa",
      "line": 170,
      "object": {
        "location": {
          "name": "cytosol",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 15,
      "target": 25
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, cytosolic levels of tau associated with membranes and, in aggregates, were significantly increased in SH-SY5Y cells cotransfected with hAPP 695 and hTau P301L (Fig. 3a). Treatment of the transfectants with MPT0G211 significantly reduced the levels of aggregated tau (Fig. 3a).",
      "key": "b8910a795c198582747f2e447e16e978",
      "line": 172,
      "object": {
        "location": {
          "name": "Tau aggregates",
          "namespace": "CONSO"
        }
      },
      "relation": "increases",
      "source": 15,
      "target": 25
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As indicated, plasmid cotransfection significantly increased HDAC6/Hsp90 binding (Fig. 4a).",
      "key": "dd261b8278269c62f328344a1d8da912",
      "line": 192,
      "relation": "increases",
      "source": 15,
      "target": 10
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",
      "key": "cf775e74dc2a88323218c44946ae7cc9",
      "line": 238,
      "relation": "increases",
      "source": 15,
      "target": 29
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",
      "key": "903796f029c220910ef5ea223a2af528",
      "line": 240,
      "relation": "increases",
      "source": 15,
      "target": 31
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",
      "key": "9a09069a03d9e5c04d8a4eea8fb7d9f3",
      "line": 242,
      "relation": "causesNoChange",
      "source": 15,
      "target": 27
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",
      "key": "51953dcfcfbb41c5a491bcd5cdae999d",
      "line": 244,
      "relation": "causesNoChange",
      "source": 15,
      "target": 28
    },
    {
      "key": "10e1166eecec1eda299119a64771a41b",
      "relation": "hasVariant",
      "source": 14,
      "target": 15
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "It is known that hyperphosphorylation also increases the capacity of tau assembles to form aggregates from oligomers to fibrils, eventually leading to their deposition as NFTs and causing neuronal dysfunction, including reduced mitochondrial respiration, altered mitochondrial dynamics, and impaired axonal transport [14].",
      "key": "b1d38b1c3b01bbdcc0193087bc9131df",
      "line": 152,
      "relation": "increases",
      "source": 26,
      "target": 11
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "It is known that hyperphosphorylation also increases the capacity of tau assembles to form aggregates from oligomers to fibrils, eventually leading to their deposition as NFTs and causing neuronal dysfunction, including reduced mitochondrial respiration, altered mitochondrial dynamics, and impaired axonal transport [14].",
      "key": "ef84776e902780e47c0031ddd62aacf0",
      "line": 153,
      "relation": "increases",
      "source": 26,
      "target": 13
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "It is known that hyperphosphorylation also increases the capacity of tau assembles to form aggregates from oligomers to fibrils, eventually leading to their deposition as NFTs and causing neuronal dysfunction, including reduced mitochondrial respiration, altered mitochondrial dynamics, and impaired axonal transport [14].",
      "key": "c0e60861162f8c644f3c519d5896bc7f",
      "line": 155,
      "relation": "increases",
      "source": 26,
      "target": 37
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "It is known that hyperphosphorylation also increases the capacity of tau assembles to form aggregates from oligomers to fibrils, eventually leading to their deposition as NFTs and causing neuronal dysfunction, including reduced mitochondrial respiration, altered mitochondrial dynamics, and impaired axonal transport [14].",
      "key": "79cc5aab5a85f255e411a366cee1eb91",
      "line": 156,
      "relation": "increases",
      "source": 26,
      "target": 41
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "It is known that hyperphosphorylation also increases the capacity of tau assembles to form aggregates from oligomers to fibrils, eventually leading to their deposition as NFTs and causing neuronal dysfunction, including reduced mitochondrial respiration, altered mitochondrial dynamics, and impaired axonal transport [14].",
      "key": "6eff050a7593bf6e3c807f77315a9544",
      "line": 157,
      "relation": "negativeCorrelation",
      "source": 26,
      "target": 6
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "It is known that hyperphosphorylation also increases the capacity of tau assembles to form aggregates from oligomers to fibrils, eventually leading to their deposition as NFTs and causing neuronal dysfunction, including reduced mitochondrial respiration, altered mitochondrial dynamics, and impaired axonal transport [14].",
      "key": "5ca2376018e53fb4949887bc4d0edecf",
      "line": 158,
      "relation": "negativeCorrelation",
      "source": 26,
      "target": 4
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "It is known that hyperphosphorylation also increases the capacity of tau assembles to form aggregates from oligomers to fibrils, eventually leading to their deposition as NFTs and causing neuronal dysfunction, including reduced mitochondrial respiration, altered mitochondrial dynamics, and impaired axonal transport [14].",
      "key": "5e9de53514aab1e04c43893a41b4aef9",
      "line": 154,
      "relation": "increases",
      "source": 13,
      "target": 12
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "It is known that hyperphosphorylation also increases the capacity of tau assembles to form aggregates from oligomers to fibrils, eventually leading to their deposition as NFTs and causing neuronal dysfunction, including reduced mitochondrial respiration, altered mitochondrial dynamics, and impaired axonal transport [14].",
      "key": "d52f8d4b27e4a086929bd4d509733af1",
      "line": 157,
      "relation": "negativeCorrelation",
      "source": 6,
      "target": 26
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "It is known that hyperphosphorylation also increases the capacity of tau assembles to form aggregates from oligomers to fibrils, eventually leading to their deposition as NFTs and causing neuronal dysfunction, including reduced mitochondrial respiration, altered mitochondrial dynamics, and impaired axonal transport [14].",
      "key": "d31febf3f9ae7e706f91ed1a4d1b4da7",
      "line": 158,
      "relation": "negativeCorrelation",
      "source": 4,
      "target": 26
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Since Hsp90 is a substrate of HDAC6, the downregulation of the expression or activity of HDAC6 has been reported to promote Hsp90 acetylation, thereby favoring tau degradation [17,18].",
      "key": "12209cabcf238916c0d6684a85d28870",
      "line": 181,
      "relation": "association",
      "source": 33,
      "target": 24
    },
    {
      "key": "2b07904c667b5ca84330c29915a55cc7",
      "relation": "hasVariant",
      "source": 33,
      "target": 34
    },
    {
      "key": "2310f42ffa03382a420a0d614772c706",
      "relation": "partOf",
      "source": 33,
      "target": 10
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "Since Hsp90 is a substrate of HDAC6, the downregulation of the expression or activity of HDAC6 has been reported to promote Hsp90 acetylation, thereby favoring tau degradation [17,18].",
      "key": "b8316130bae6ed6e470e6ef7a4b093d5",
      "line": 183,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 34,
      "target": 25
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, MPT0G211 treatment clearly enhanced the acetylation of Hsp90, which caused the downregulation of HDAC6/Hsp90 binding (Fig. 4a).",
      "key": "0e874376ac19bfa1d87f03d8a22960f4",
      "line": 200,
      "relation": "decreases",
      "source": 34,
      "target": 10
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In cells treated with MPT0G211, coimmunoprecipitation of ubiquitin with p-tau (Ser396) clearly increased (Fig. 4b), and the level of polyubiquitinated proteins significantly accumulated (Fig. 4c).",
      "key": "01cf2b56f2772f12949429d605cf08ce",
      "line": 209,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 30,
      "target": 25
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, proteasome inhibitor MG132 treatment significantly reversed the MPT0G211- induced inhibition of p-tau at Ser396 in both cell lines (Fig. 4d).",
      "key": "43714cd187b2bc98769859d7898abfce",
      "line": 219,
      "relation": "increases",
      "source": 3,
      "target": 29
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, the activity of GSK3β is dependent on its phosphorylation at specific sites, including Ser9 and Tyr216, which can inhibit or increase GSK3β activity, respectively [19].",
      "key": "d39b44eadc2d0fa3989629b927d4e060",
      "line": 227,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 22,
      "target": 20
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "MPT0G211 treatment significantly attenuated the phosphorylation of tau Ser396 and Ser404 in both cell lines (Fig. 5a); no marked changes in CDK5, p25, or p35 expression were associated with MPT0G211-induced phospho-tau downregulation; however, significant phospho-GSK3β increases on Ser9 through Akt phosphorylation were associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment (Fig. 5b).In addition, a decrease in phospho-GSK3β on Ser216 was also observed.",
      "key": "ebdeb3d9c118f0b5dedb705456ae428f",
      "line": 264,
      "relation": "decreases",
      "source": 22,
      "target": 29
    },
    {
      "key": "ad1f4bccab8e8cd26c9596157cfd762d",
      "relation": "hasVariant",
      "source": 20,
      "target": 22
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, the activity of GSK3β is dependent on its phosphorylation at specific sites, including Ser9 and Tyr216, which can inhibit or increase GSK3β activity, respectively [19].",
      "key": "51614d3410782ef47b3ae23392dcec7e",
      "line": 227,
      "relation": "association",
      "source": 20,
      "subject": {
        "modifier": "Activity"
      },
      "target": 22
    },
    {
      "key": "3fe4b81a2dc26987b4f660af8b7945e1",
      "relation": "hasVariant",
      "source": 20,
      "target": 23
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, the activity of GSK3β is dependent on its phosphorylation at specific sites, including Ser9 and Tyr216, which can inhibit or increase GSK3β activity, respectively [19].",
      "key": "c507946199f4c70eea6a1491c22dceeb",
      "line": 228,
      "relation": "association",
      "source": 20,
      "subject": {
        "modifier": "Activity"
      },
      "target": 23
    },
    {
      "key": "7c5f95bb45012aee883af60545d9043c",
      "relation": "hasVariant",
      "source": 20,
      "target": 21
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "In addition, the activity of GSK3β is dependent on its phosphorylation at specific sites, including Ser9 and Tyr216, which can inhibit or increase GSK3β activity, respectively [19].",
      "key": "e5adc72b27d5e5e8ff6b9f5e4eb51e93",
      "line": 228,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 23,
      "target": 20
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "MPT0G211 treatment significantly attenuated the phosphorylation of tau Ser396 and Ser404 in both cell lines (Fig. 5a); no marked changes in CDK5, p25, or p35 expression were associated with MPT0G211-induced phospho-tau downregulation; however, significant phospho-GSK3β increases on Ser9 through Akt phosphorylation were associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment (Fig. 5b).In addition, a decrease in phospho-GSK3β on Ser216 was also observed.",
      "key": "02cc6eeabe303d615bf04564b2a1da9c",
      "line": 263,
      "relation": "increases",
      "source": 17,
      "target": 22
    },
    {
      "key": "9dd8189a2b3a5de1bfa7880431999146",
      "relation": "hasVariant",
      "source": 16,
      "target": 17
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As reported, Aβ 1–40-induced significant p-GSK3β (Ser9) attenuation and increase in p-tau (Ser396); MPT0G211 treatment diminished GSK3β activity and Aβ 1–40-induced tau phosphorylation (Fig. 5c).",
      "key": "3a92824a143f6d8bf2e9230018ebbf82",
      "line": 274,
      "relation": "decreases",
      "source": 0,
      "target": 22
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Fan SJ",
          "Huang FI",
          "Liou JP",
          "Yang CR"
        ],
        "date": "2018-05-29",
        "db": "PubMed",
        "db_id": "29844403",
        "db_name": "The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.",
        "first": "Fan SJ",
        "journal": "Cell death & disease",
        "last": "Yang CR",
        "pages": "655",
        "volume": "9"
      },
      "evidence": "As reported, Aβ 1–40-induced significant p-GSK3β (Ser9) attenuation and increase in p-tau (Ser396); MPT0G211 treatment diminished GSK3β activity and Aβ 1–40-induced tau phosphorylation (Fig. 5c).",
      "key": "a98b772f48780e1e573fb772a94898aa",
      "line": 275,
      "relation": "increases",
      "source": 0,
      "target": 29
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 40\")",
      "concept": {
        "name": "amyloid-beta polypeptide 40",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9e0dfb730cc36c0afbaa05a340211fda"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(PUBCHEM:132157820)",
      "concept": {
        "name": "132157820",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "57983387ccef79368c895b02658184bf"
    },
    {
      "bel": "a(PUBCHEM:462382)",
      "concept": {
        "name": "462382",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "864edef638e65ba94f078b33086e3072"
    },
    {
      "bel": "bp(GO:\"axonal transport\")",
      "concept": {
        "name": "axonal transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c9d614fb05004498d4069f216f0458c8"
    },
    {
      "bel": "bp(GO:\"cell death\")",
      "concept": {
        "name": "cell death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "07a2f2734c3682bcb47105485c15b346"
    },
    {
      "bel": "bp(GO:\"cellular respiration\")",
      "concept": {
        "name": "cellular respiration",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ced509226a10b89fb0f158c6a90c60c2"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:learning)",
      "concept": {
        "name": "learning",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "75fc4f4e732353b87f83a4a8174ffb29"
    },
    {
      "bel": "bp(GO:memory)",
      "concept": {
        "name": "memory",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "e03a718b44a1ff30acea5c31966879a9"
    },
    {
      "bel": "complex(p(HGNC:HDAC6), p(HGNCGENEFAMILY:\"Heat shock 90kDa proteins\"))",
      "function": "Complex",
      "id": "94da2156965d518b96086b135c8bc413",
      "members": [
        {
          "bel": "p(HGNC:HDAC6)",
          "concept": {
            "name": "HDAC6",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8f10ead99d8970092c3980eb37bcfb3a"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Heat shock 90kDa proteins\")",
          "concept": {
            "name": "Heat shock 90kDa proteins",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "b77a62c6d507753b144b413e4839d252"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "d03adc6b1e424e742ba646d63a61f48e"
    },
    {
      "bel": "p(CONSO:\"Tau fibrils\")",
      "concept": {
        "name": "Tau fibrils",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "0fa53bcd9e91fea7f61fb06070df8ff9"
    },
    {
      "bel": "p(CONSO:\"Tau oligomers\")",
      "concept": {
        "name": "Tau oligomers",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "541ac886014140ca02c1076bebd9f2f9"
    },
    {
      "bel": "p(CONSO:APP695)",
      "concept": {
        "name": "APP695",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "ba28182338c4f6d3ed53e754a249762c"
    },
    {
      "bel": "p(CONSO:APP695, var(\"?\"))",
      "concept": {
        "name": "APP695",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "7bf67512c7d1738bddb66ed2f45dccfb",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(FPLX:AKT)",
      "concept": {
        "name": "AKT",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "e0ada1edbf208bbaa7cb0798a2462eb3"
    },
    {
      "bel": "p(FPLX:AKT, pmod(Ph))",
      "concept": {
        "name": "AKT",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "4cd682f5a280ba91aeef5091781c4061",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:CDK5)",
      "concept": {
        "name": "CDK5",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cb1e1b28f1d3fe30db837d601f26fe1b"
    },
    {
      "bel": "p(HGNC:CDK5R1)",
      "concept": {
        "name": "CDK5R1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "386aa7422eaa152faa763b873a474731"
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "concept": {
        "name": "GSK3B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8eaf29c9e491ff4e49619e77de92467c"
    },
    {
      "bel": "p(HGNC:GSK3B, pmod(Ph, Ser, 216))",
      "concept": {
        "name": "GSK3B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7b4b04fde7d99b2b74726b24e561e35c",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 216
        }
      ]
    },
    {
      "bel": "p(HGNC:GSK3B, pmod(Ph, Ser, 9))",
      "concept": {
        "name": "GSK3B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3c0d44ec2ec04e34ffcc49f33af047ff",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 9
        }
      ]
    },
    {
      "bel": "p(HGNC:GSK3B, pmod(Ph, Tyr, 216))",
      "concept": {
        "name": "GSK3B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "246ac034aa49b8ff5cf7278824978dc1",
      "variants": [
        {
          "code": "Tyr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 216
        }
      ]
    },
    {
      "bel": "p(HGNC:HDAC6)",
      "concept": {
        "name": "HDAC6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8f10ead99d8970092c3980eb37bcfb3a"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0d2d8072f03dcdf148e658067d37b9cb",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 262))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "06b0d7203a7f93cbb663eab8b9b593ab",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 262
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 356))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5eb6d95220e92f14e6fd76a31f51dcd4",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 356
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 396))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d20659abb6d812839958a31e9d5d259b",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 396), pmod(Ub))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "aa18c9496fe8a9b1700ddd0b853d687d",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        },
        {
          "concept": {
            "name": "Ub",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 404))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c0bfbdd9489341f82d82ce560ba52523",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 404
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, var(\"p.Pro301Leu\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ba35d8874023cf0115d435afc490b61b",
      "variants": [
        {
          "hgvs": "p.Pro301Leu",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Heat shock 90kDa proteins\")",
      "concept": {
        "name": "Heat shock 90kDa proteins",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "b77a62c6d507753b144b413e4839d252"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Heat shock 90kDa proteins\", pmod(Ac))",
      "concept": {
        "name": "Heat shock 90kDa proteins",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "666c688f0e82ffc1bff2c93c6b8d3d57",
      "variants": [
        {
          "concept": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(INTERPRO:\"Alpha tubulin\")",
      "concept": {
        "name": "Alpha tubulin",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "2b4985733912e25a1c639112bb278eef"
    },
    {
      "bel": "p(INTERPRO:\"Alpha tubulin\", pmod(Ac))",
      "concept": {
        "name": "Alpha tubulin",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "446d9f3763ca55de80d3e407e35199ac",
      "variants": [
        {
          "concept": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MESH:\"Neurofibrillary Tangles\")",
      "concept": {
        "name": "Neurofibrillary Tangles",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "23b57fa4c2111fd8150d349cd2c5c2d0"
    },
    {
      "bel": "p(MESH:Histones)",
      "concept": {
        "name": "Histones",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "82e6f3e18179200309900dc380f441b4"
    },
    {
      "bel": "p(MESH:Histones, pmod(Ac))",
      "concept": {
        "name": "Histones",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "3034ed0bfa0794f39d215e5c22420266",
      "variants": [
        {
          "concept": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "path(DOID:\"Alzheimer's disease\")",
      "concept": {
        "name": "Alzheimer's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "bab8638a4ae2b144ee036438e0a858da"
    },
    {
      "bel": "path(DOID:neuropathy)",
      "concept": {
        "name": "neuropathy",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "943823133ae72d328485574207be5347"
    },
    {
      "bel": "path(HP:\"Abnormal synaptic transmission\")",
      "concept": {
        "name": "Abnormal synaptic transmission",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "2a693aae72629044421f59d88f9981fb"
    },
    {
      "bel": "path(MESH:\"Cytotoxicity, Immunologic\")",
      "concept": {
        "name": "Cytotoxicity, Immunologic",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "29f01312a1c95ba0231e0d65de10c710"
    }
  ]
}